NLS Pharmaceutics Ltd.为扩大其制药业务，已与生物技术公司Kadimastem Ltd.达成合并协议。根据今天宣布的协议，Kadimastem将合并入NLS的一家全资子公司，该子公司将作为存续实体继续运营。

ZURICH, SWITZERLAND and NESS ZIONA, ISRAEL / ACCESSWIRE / November 4, 2024 / Ltd. (NASDAQ:NLSP) ("NLS"), a biopharmaceutical ...

NLS Pharmaceutics (NLSP) has released an update. Kadimastem Ltd. faces significant financial challenges as its recent audit reveals recurring losses and a negative cash flow, casting doubt on its ...

此外，NLS Pharmaceutics宣布与Kadimastem Ltd进行战略合并，使Kadimastem成为NLS的全资子公司。这次合并将促进Kadimastem细胞治疗平台的发展。公司还报告了针对帕金森病的化合物的成功临床前结果，计划开发两种新的后续产品AEX-230和AEX-231用于神经退行性疾病。

Chemistry is at the centre of our existence and offers transformative solutions to many global challenges, including health. RSC Pharmaceutics acknowledges how chemistry and related disciplines can ...

Pharmaceutics is the scientific discipline concerned with the process of creating the dosage form (such as a pill for oral administration or a powder for intravenous injection) of a therapeutic ...

NLS Pharmaceutics (NLSP) rose in premarket trading on Monday after the company reported a definitive merger agreement with ...

NLS Pharmaceutics (NLSP) has released an update. NLS Pharmaceutics is undertaking a significant restructuring effort by proposing an ordinary ...

NLS Pharmaceutics Ltd. (NASDAQ:NLSP) shares are moving higher on Monday after the company announced it entered into a ...

NLS Pharmaceutics (NLSP) and Kadimastem announced that they have entered into a definitive merger agreement to combine the two companies to focus on advancing NLS’ promising, first-in class Dual ...

NLS Pharmaceutics announced it entered into a definitive merger agreement with Kadimastem. One goal of the combined company is to advance NLS's Dual Orexin Agonist platform. NLS Pharmaceutics Ltd.

ZURICH, SWITZERLAND and NESS ZIONA, ISRAEL / ACCESSWIRE / November 4, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP) ("NLS"), a biopharmaceutical company, and Kadimastem ...